Globus Medical, Inc. (BMV:GMED)

Globus Medical Statistics

Total Valuation

Globus Medical has a market cap or net worth of MXN 220.66 billion. The enterprise value is 211.80 billion.

Market Cap	220.66B
Enterprise Value	211.80B

Important Dates

The last earnings date was Tuesday, February 24, 2026.

Earnings Date	Feb 24, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	112.82M
Shares Outstanding	n/a
Shares Change (YoY)	-0.59%
Shares Change (QoQ)	+0.87%
Owned by Insiders (%)	17.05%
Owned by Institutions (%)	86.99%
Float	111.93M

Valuation Ratios

The trailing PE ratio is 22.79 and the forward PE ratio is 20.76.

PE Ratio	22.79
Forward PE	20.76
PS Ratio	4.17
PB Ratio	2.68
P/TBV Ratio	5.12
P/FCF Ratio	20.82
P/OCF Ratio	16.27
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.52, with an EV/FCF ratio of 19.98.

EV / Earnings	21.87
EV / Sales	4.14
EV / EBITDA	13.52
EV / EBIT	20.29
EV / FCF	19.98

Financial Position

The company has a current ratio of 4.26, with a Debt / Equity ratio of 0.03.

Current Ratio	4.26
Quick Ratio	2.61
Debt / Equity	0.03
Debt / EBITDA	0.13
Debt / FCF	0.20
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 12.29% and return on invested capital (ROIC) is 12.91%.

Return on Equity (ROE)	12.29%
Return on Assets (ROA)	7.11%
Return on Invested Capital (ROIC)	12.91%
Return on Capital Employed (ROCE)	12.49%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	8.82M
Profits Per Employee	1.61M
Employee Count	6,000
Asset Turnover	0.56
Inventory Turnover	1.32

Taxes

In the past 12 months, Globus Medical has paid 1.21 billion in taxes.

Income Tax	1.21B
Effective Tax Rate	11.11%

Stock Price Statistics

The stock price has decreased by -5.43% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-5.43%
50-Day Moving Average	1,392.65
200-Day Moving Average	n/a
Relative Strength Index (RSI)	59.02
Average Volume (20 Days)	554

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.33

Income Statement

In the last 12 months, Globus Medical had revenue of MXN 52.91 billion and earned 9.68 billion in profits. Earnings per share was 70.57.

Revenue	52.91B
Gross Profit	36.02B
Operating Income	10.81B
Pretax Income	10.89B
Net Income	9.68B
EBITDA	15.79B
EBIT	10.81B
Earnings Per Share (EPS)	70.57

Balance Sheet

The company has 10.03 billion in cash and 2.15 billion in debt, with a net cash position of 9.17 billion.

Cash & Cash Equivalents	10.03B
Total Debt	2.15B
Net Cash	9.17B
Net Cash Per Share	n/a
Equity (Book Value)	82.33B
Book Value Per Share	609.63
Working Capital	29.29B

Cash Flow

In the last 12 months, operating cash flow was 13.56 billion and capital expenditures -2.96 billion, giving a free cash flow of 10.60 billion.

Operating Cash Flow	13.56B
Capital Expenditures	-2.96B
Free Cash Flow	10.60B
FCF Per Share	n/a

Margins

Gross margin is 68.07%, with operating and profit margins of 20.42% and 18.30%.

Gross Margin	68.07%
Operating Margin	20.42%
Pretax Margin	20.59%
Profit Margin	18.30%
EBITDA Margin	29.84%
EBIT Margin	20.42%
FCF Margin	20.03%

Dividends & Yields

Globus Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.59%
Shareholder Yield	0.59%
Earnings Yield	4.39%
FCF Yield	4.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Globus Medical has an Altman Z-Score of 9.47 and a Piotroski F-Score of 7.

Altman Z-Score	9.47
Piotroski F-Score	7